A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial-Reference-Cited by-同舟云学术

A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial

Published:2017-10 Issue:10 Volume:5 Page:806-815
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Birring Surinder S,Wijsenbeek Marlies S,Agrawal Sanjay,van den Berg Jan W K,Stone Helen,Maher Toby M,Tutuncu Ahmet,Morice Alyn H

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference66 articles.

1. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management;Raghu;Am J Respir Crit Care Med,2011

2. Incidence and prevalence of idiopathic pulmonary fibrosis;Raghu;Am J Respir Crit Care Med,2016

3. Cough predicts prognosis in idiopathic pulmonary fibrosis;Ryerson;Respirology,2011

4. Objective cough frequency in idiopathic pulmonary fibrosis;Key;Cough,2010

5. Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives;Swigris;Health Qual Life Outcomes,2005

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The burden of cough in idiopathic pulmonary fibrosis and other interstitial lung diseases: a systematic evidence synthesis;Respiratory Research;2024-08-27

2. What causes cough in pulmonary fibrosis, and how should we treat it?;Current Opinion in Pulmonary Medicine;2024-06-24

3. Cough Severity Visual Analog Scale Assesses Cough Burden and Predicts Survival in Idiopathic Pulmonary Fibrosis;American Journal of Respiratory and Critical Care Medicine;2024-05-01

4. Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects;Journal of Nanobiotechnology;2024-03-29

5. Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision;Respirology;2024-01-11